Summary
The discovery of the clinical efficacy of imipramine and of the MAO-inhibitor iproniazid intensively stimulated biochemical-pharmacological research on the mechanism of action of antidepressants. Due to these investigations, until recently an enhanced activity of the central noradrenergic and/or serotonergic transmitter system was considered essential for the clinical antidepressive action. Such enhancement could be achieved either presynaptically by blocking α2-adrenergic receptors, or in the synaptic cleft by inhibiting the transmitter reuptake or the main metabolic enzyme, MAO. The common final result, especially of chronic treatment, was the down-regulation of postsynaptic β-receptors, modulated by interaction with the serotonergic system, neuropeptides, and hormones. The delay of clinical response corresponded better with such receptor alterations. However, the introduction of new, more selective antidepressants led to new reflections upon the mechanism of action. On the level of transmitters, α1upregulation, increased activity of the dopaminergic system, an alteration in the balance between the different transmitter systems, are reported and seem to be important. Most promising are recent investigations of the second messenger systems, the adenylate cyclase system and the phosphatidylinositol system. Both systems are modulated by antidepressant drugs including lithium and carbamazepine. These second messengers, in turn, modulate the phosphorylation status of neuronal proteins via protein kinase, which may lead to elevations of the above mentioned receptors and again their transduction systems.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aghajanian GK, Sprouse JS, Rasmussen K (1987) Physiology of the midbrain serotonin system. In: Meltzer HY (ed) Psychopharmacology: the third generation of progress. Raven Press, New York, pp 127–141.
Arenander AT, de Vellis J, Herschman HR (1989) Induction of c-fos and TIS genes in cultured rat astrocytes by neurotransmitters. J Neurosci Res 24:107–114.
Avissar S, Schreiber G, Danon R, Belmaker H (1988) Lithium inhibits adrenergic and cholinergic increase in GTP binding in rat cortex. Nature 331:440–442.
van Calker D, Steber R, Klotz K-N, Greil W (1990) Carbamazepine distinguishes between adenosine receptor syptypes that mediate, respectively, regulation of cyclic AMP accumulation and inhibition of inositolphosphate formation. (Submitted).
Ceccatelli S, Villar MJ, Goldstein M, Hökfelt T (1989) Expression of c-fos immunoreactivity in transmitter-characterized neurons after stress. Proc Natl Acad Sci USA 86:9569–9573.
Checkley SA (1988) Monoamines, depression and antidepressant drugs. Pharmacopsychiatry 21:6–8.
Checkley SA, Thompson C, Burton S, Francy C, Arendt J (1985) Clinical studies of the effect of (+) and (−)-oxaprotiline upon noradrenaline uptake. Psychopharmacology 87:116–118.
Comb M, Hyman SE, Goodman HM (1987) Mechanism of trans-synaptic regulation of gene expression. TINS 10(11):473–478.
Coppen A (1967) The biochemistry of affective disorders. Br J Psychiatry 113:1237–1264.
Crane GE (1957) Iproniazid (Marsilid) phosphate a therapeutic agent for mental disorders and debilitating diseases. Psychiat Res Rep Am Psychiat Ass 8:142–152.
Delini-Stula A, Mogilnicka E (1988) Single treatments with the antidepressant oxaprotiline and its (+) and (−) enantiomers increase behavioural responses to dopaminergic stimulation in the rat. J Neural Transm 71:91–98.
Delini-Stula A, Mogilnicka E (1989) Rapid changes in functional responsiveness of the 5-HT system after single-dose and multiple-dose treatment with antidepressants: effects of maprotiline and oxaprotiline and its enantiomers. J Pharmacol 3(1):7–13.
Delini-Stula A, Radeke E, van Riezen H (1988) Enhanced functional responsiveness of the dopaminergic system — the mechanism of anti-immobility effects of antidepressants in the behavioural despair test in the rat. Neuropharmacology 27(9):943–947.
Dousa T, Hechter O (1970) Lithiuim and brain adenyl cyclase. Lancet i:834–835.
Eccelston D (1981) Monoamines in affective illness — is there a place for 5-HT?. Br J Psychiatry 138:257–258.
Engel G, Göthert M, Hoyer D, Schlicker E, Hillenbrand K (1986) Identity of inhibitory presynaptic 5-hydroxytryptamine (5-HT) autoreceptors in the rat brain cortex with 5-HT1B binding sites. Nauyn-Schmiedebergs Arch Pharmacol 357:1–7.
Feuerstein TJ, Hertting G, Jackisch R (1985) Endogenous noradrenaline as modular of hippocampal serotonin (5-HT)-release. Naunyn-Schmiedebergs Arch Pharmacol 329:216–221.
Fuxe K, Calza L, Benfenati F, Zini I, Agnati LF (1983) Quantitative autoradiographic localization of [3H]imipramine binding sites in the brain of the rat: relationship to ascending 5-hydroxytryptamine neuron systems. Proc Natl Acad Sci USA 80:3836–3840.
Hadrock JR, Malbon CC (1988) Down-regulation of beta-adrenergic receptors: Agonist-induced reduction in receptor mRNA levels. Proc Natl Acad Sci USA 85:5021–5025.
Hallcher LM, Sherman WR (1980) The effects of lithium ion and other agents on the activity of myo-inositol-1-phosphate from bovine brain. J Biol Chem 225:10896–10901.
Kilpatrick GJ, Jones BJ, Tyers MB (1987) Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding. Nature 330:746–748.
Kuhn R (1957) Über die Behandlung depressiver Zustände mit einem Iminodibenzylderivat (G 22 455). Schweiz Med Wochenschr 35/36:1135–1140.
Langer SZ (1978) Presynaptic receptors and the regulation of transmitter release in the peripheral and central nervous system: physiological and pharmacological significance. In: Catecholamines: basic and clinical frontiers. Proc 4th Int Catecholamine Symposium. Pergamon Press, London, New York.
Maj J (1990) Pharmakologie von Levoprotilin. (In preparation).
Maj J, Wedzony K (1988) The influence of oxaprotiline enantiomers given repeatedly on the behavioural effects of d-amphetamine and dopamine injected into the nucleus accumbens. Eur J Pharmacol 145:97–103.
Matussek N (1969) Die Catecholamin-und Serotoninhypothese der Depression. In: Hippius H, Selbach H (Hrsg) Das depressive Syndrom. Urban & Schwarzenberg, München Berlin Wien.
Matussek N, Ackenheil M, Hippius H, Müller F, Schröder HT, Schultes H, Wasilewski B (1980) Effect of clonidine on growth hormone release in psychiatrie patients and controls. Psychiatry Res:25-36.
Meltzer HY, Lowry MT (1987) The serotonin hypothesis of depression. In: Meltzer HY (ed) Psychopharmacology: the third generation of progress. Raven Press, New York, pp 513–526.
Mogilnicka E, Boissard CG, Waldmeier PC, Delini-Stula A (1983) The effects of single and repeated doses of maprotiline, oxaprotiline and its enantiomers on foot-shock induced fighting in rats. Pharmacol Biochem Behav 19:719–723.
Mogilnicka E, Zazula M, Wedzony K (1987) Functional supersensitivity to the α1 adrenoceptor agonist after repeated treatment with antidepressant drugs is not conditioned by β-down-regulation. Neuropharmacology 26(10): 1457–1461.
Morgan JI, Curran T (1989) Stimulus-transcription coupling in neurons: role of cellular immediate-early genes. TINS 12(11):459–462.
Newman ME, Klein E, Birnmaher B, Feinsod M, Belmaker H (1983) Lithium at therapeutic concentrations inhibits human brain noradrenaline-sensitive cAMP accumulation. Brain Res 278:380–381.
Olpe HR, Schellenberg (1981) Rotubule fractions of rat cerebral cortex after prolonged desmethyl-imipramine treatment. Eur J Pharmacol-Mol Pharmacol Section 172:305–316.
Perez J, Tinelli D, Brunello N, Racagni G (1989) CAMP-dependent phosphorylation of sulble and crude microtube fractions of rat cerebral cortex after prolonged desmethylimipramine treatment. Eur J Pharmacol-Mol Pharmacol Section 172:305–316.
Peroutka SJ (1987) Serotonin receptors. In: Meltzer HY (ed) Psychopharmacology: the third generation of progress. Raven Press, New York, pp 303–311.
Potter WZ, Scheinin M, Golden RN (1985) Selective antidepressants and cerebrospinal fluid. Arch Gen Psychiatry 42:1171–1177.
Pritchett DB, Bach AW, Wozny M, Taleb O, Dal Toso R, Shih J, Seeburg PH (1988) Structure and functional expression of cloned rat serotonin 5-HT2 receptor. EMBO J 7:4135–4140.
Racagni G, Brunello N (1984) Transsynaptic mechanisms in the action of antidepressant drugs. Trends Pharmacol Sci 5:527.
Randrup A, Braestrup C (1977) Uptake inhibition of biogenic amines by newer antidepressant drugs: relevance to the dopamine hypothesis of depression. Psychopharmacology 53:309–314.
Robertson HA, Peterson MR, Murphy K, Robertson GS (1989) Dl-dopamine receptor agonists selectively activate striatal c-fos independent of rotational behaviour. Brain Res 503:346–349.
Schildkraut JJ (1965) The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry 122:509–522.
Vetulani J, Sulser F (1975) Action of various antidepressant treatments reduces reactivity of noradrenergic cyclic AMP-generating system in limbic forebrain. Nature 257:495–497.
Wachtel H (1983) Potential antidepressant activity of rolipram and other selective cyclic adenosine 3′,5′-monophosphate phosphodiesterase inhibitors. Neuropharmacology 22:367–372.
Wachtel H (1990) The second-messenger dysbalance hypothesis of affective disorders. Pharmacopsychiatry 23:27–32.
Waldmeier PC, Baumann PA, Hauser K, Maître L, Storni A (1982) Oxaprotiline, a noradrenaline uptake inhibitor with an active and an inactive enantiomer. Biochem Pharmacol 31(12):2169–2176.
Wander TJ, Nelson A, Okazaki H, Richelson E (1986) Antagonism by antidepressants of serotonin S1 and S2 receptors of normal human brain in vitro. Eur J Pharmacol 132:115–121.
Wendt G, Binz U (1989) Levoprotilin. Therapeutische Wirksamkeit und Verträglichkeit am Beispiel einer Doppelblind-Studie vs. Amitriptylin. Münch Med Wochenschr 131(2):0–0.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer-Verlag
About this paper
Cite this paper
Ackenheil, M. (1990). The mechanism of action of antidepressants revised. In: Riederer, P., Youdim, M.B.H. (eds) Amine Oxidases and Their Impact on Neurobiology. Journal of Neural Transmission, vol 32. Springer, Vienna. https://doi.org/10.1007/978-3-7091-9113-2_3
Download citation
DOI: https://doi.org/10.1007/978-3-7091-9113-2_3
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-82239-5
Online ISBN: 978-3-7091-9113-2
eBook Packages: Springer Book Archive